Literature DB >> 1876667

Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: influence of gender, instruction, personality and placebo.

F S Guimarães1, J Hellewell, R Hensman, M Wang, J F Deakin.   

Abstract

Two experiments are described which evaluate the role of associative mechanisms and placebo effects on aversively conditioned skin conductance responses in groups of healthy volunteers. In both experiments, skin conductance level (SCL), variability (spontaneous fluctuations, SF) and amplitude (SCR) were recorded during a sequence of tone stimuli (80 dB, 1 s, 360 Hz). All the variables habituated during the first ten presentations of the tones. Tone 11 was immediately followed by a loud (100 dB) aversive brief (1 s) white noise UCS. The conditioning trial significantly enhanced SCRs to a further ten presentations of the tones and increased SCL and variability (SF). No enhancement of SCRs occurred when tone 11 was omitted and the UCS occurred in temporal isolation (experiment 1). Thus enhanced SCRs to tones following paired tone-noise presentation involves an associative mechanism. Increased "spontaneous" variability was shown to involve both conditioning and sensitization following the UCS. In both experiments females showed greater conditioned SCRs than males. In experiment 2 no effect of "anxiolytic" placebo could be discerned and there were no general relationships between questionnaires scores of extraversion or neuroticism with skin conductance measures in a group of 40 volunteers. The results question the role of conditionability and autonomic lability as major determinants of extraversion and neuroticism. These studies validate the use of the psychophysiological model of aversive conditioning in pharmacological studies of the mechanisms of habituation, conditioning and sensitization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1876667     DOI: 10.1007/bf02244184

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  CHARACTERISTICS OF A CONDITIONED RESPONSE IN HUMAN SUBJECTS DURING EXTINCTION TRIALS FOLLOWING A SINGLE TRAUMATIC CONDITIONING TRIAL.

Authors:  D CAMPBELL; R E SANDERSON; S G LAVERTY
Journal:  J Abnorm Psychol       Date:  1964-06

2.  The effects of consent procedures on the psychophysiological assessment of anxiety: a methodological inquiry.

Authors:  J G Farha; K J Sher
Journal:  Psychophysiology       Date:  1989-03       Impact factor: 4.016

3.  Test of the conditioning model of neurosis: differential aversive conditioning of angry and neutral facial expressions in anxiety disorder patients.

Authors:  R K Pitman; S P Orr
Journal:  J Abnorm Psychol       Date:  1986-08

4.  Sex differences in skin conductance measures as a function of shock threat.

Authors:  F M Kopacz; B D Smith
Journal:  Psychophysiology       Date:  1971-05       Impact factor: 4.016

5.  Effects of set and sex on the electrodermal orienting response.

Authors:  J H Korn; K E Moyer
Journal:  Psychophysiology       Date:  1968-04       Impact factor: 4.016

6.  Changes in psychophysiological and conditioning variables during chlormethiazole-medicated and unmedicated ethanol withdrawal: preliminary report.

Authors:  M Wang
Journal:  Acta Psychiatr Scand Suppl       Date:  1986

7.  Vulnerability and conditioning in relation to the human menstrual cycle.

Authors:  J Vila; H R Beech
Journal:  Br J Soc Clin Psychol       Date:  1977-02
  7 in total
  12 in total

1.  The influence of gonadal hormones on conditioned fear extinction in healthy humans.

Authors:  M R Milad; M A Zeidan; A Contero; R K Pitman; A Klibanski; S L Rauch; J M Goldstein
Journal:  Neuroscience       Date:  2010-04-22       Impact factor: 3.590

2.  Cortisol effects on fear memory reconsolidation in women.

Authors:  Shira Meir Drexler; Christian J Merz; Tanja C Hamacher-Dang; Oliver T Wolf
Journal:  Psychopharmacology (Berl)       Date:  2016-05-02       Impact factor: 4.530

3.  Effects of ritanserin on aversive classical conditioning in humans.

Authors:  R Hensman; F S Guimarães; M Wang; J F Deakin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Is aversive learning a marker of risk for anxiety disorders in children?

Authors:  Michelle G Craske; Allison M Waters; R Lindsey Bergman; Bruce Naliboff; Ottmar V Lipp; Hideki Negoro; Edward M Ornitz
Journal:  Behav Res Ther       Date:  2008-05-01

5.  Modelling anxiety in humans for drug development.

Authors:  Martin Siepmann; Peter Joraschky
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

6.  Evaluation of a psychophysiological model of classical fear conditioning in anxious patients.

Authors:  K R Ashcroft; F S Guimarães; M Wang; J F Deakin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Sex differences in fear conditioning in posttraumatic stress disorder.

Authors:  Sabra S Inslicht; Thomas J Metzler; Natalia M Garcia; Suzanne L Pineles; Mohammed R Milad; Scott P Orr; Charles R Marmar; Thomas C Neylan
Journal:  J Psychiatr Res       Date:  2012-10-26       Impact factor: 4.791

8.  Rapid prefrontal cortex activation towards aversively paired faces and enhanced contingency detection are observed in highly trait-anxious women under challenging conditions.

Authors:  Maimu Alissa Rehbein; Ida Wessing; Pienie Zwitserlood; Christian Steinberg; Annuschka Salima Eden; Christian Dobel; Markus Junghöfer
Journal:  Front Behav Neurosci       Date:  2015-06-10       Impact factor: 3.558

9.  Contextual control over expression of fear is affected by cortisol.

Authors:  Vanessa A van Ast; Bram Vervliet; Merel Kindt
Journal:  Front Behav Neurosci       Date:  2012-10-11       Impact factor: 3.558

Review 10.  Human fear conditioning and extinction in neuroimaging: a systematic review.

Authors:  Christina Sehlmeyer; Sonja Schöning; Pienie Zwitserlood; Bettina Pfleiderer; Tilo Kircher; Volker Arolt; Carsten Konrad
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.